ExamPat

Dwayne C Jones

USPTO Patent Examiner·Active 2012 to 2022

Dwayne C Jones is a USPTO patent examiner who has handled 30 ex parte reexaminations between 2012 and 2022. These reexams concentrate in Chemistry & Materials, Life Sciences & Consumer, and Mechanical & Manufacturing. ExamPat indexes the full prosecution record for each of these cases, including office-action grounds, certificate outcomes, and downstream PTAB and federal-circuit decisions.

Filings by year

8
12
3
13
3
14
6
15
2
16
3
19
1
20
4
21
1
22

Technology mix

Chemistry & Materials15 (48%)
Life Sciences & Consumer14 (45%)
Mechanical & Manufacturing1 (3%)

Compare against all examiners

Eight side-by-side metrics: case volume, pendency, OAs per reexam, rejection mix, SNQ denial rate, certification rate, and PTAB appeal rate, with a Δ column showing where this examiner runs higher or lower than the corpus.

  • Average and median pendency, both for this examiner and the corpus
  • Rejection basis split (102 / 103 / 112) head-to-head
  • Certification, SNQ denial, and PTAB appeal rates

Certificate outcome distribution

How this examiner's certificates split across the six possible outcomes: all claims confirmed, confirmed with amendment, confirmed with new claims, mixed, or all claims canceled. Includes share comparison to the corpus distribution.

  • Count and share for each of the six outcome buckets
  • Δ vs. corpus distribution in percentage points
  • Useful for setting realistic patent-owner expectations

Event-to-event timing

Median time for this examiner's cases at each prosecution stage — filing to first office action, filing to NIRC, and filing to certificate — with corpus comparison and sample size.

  • Median in months per transition
  • Side-by-side with the corpus median
  • n column showing how many of this examiner's cases completed each transition

Recent reexaminations (showing 25 of 30)

Control #FiledPatentTitlePendencyStatus
90/015,012Apr 21, 202211,129,912RADIOPHARMACEUTICAL AND METHODS11 moClosed
90/014,929Dec 22, 20218,435,570NITRATE FORMULATIONS AND THEIR USE AS NITRIC OXIDE PRODRUGS14 moClosed
90/014,822Aug 9, 20218,197,875TASTE MODIFIERS COMPRISING A CHLOROGENIC ACID11 moClosed
90/014,726Apr 13, 202110,973,898Gel for Treating Infectious Bronchitis17 moClosed
90/014,657Jan 22, 202110,894,721WATER-SOLUBLE ELECTROLYZED/SOLVOLYZED CLINOPTILOLITE FRAGMENTS AND NUTRACEUTICAL, PHARMACEUTICAL, AND ENVIRONMENTAL PRODUCTS BASED THEREON13 moClosed
90/014,597Oct 26, 20207,872,072Branched Polymers and their Conjugates14 moClosed
90/014,390Oct 16, 201910,131,682HYDROPHILIC LINKERS AND THEIR USES FOR CONJUGATION OF DRUGS TO A CELL BINDING MOLECULES15 moClosed
90/014,321Jun 20, 20199,868,707SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 15 moClosed
90/014,265Feb 18, 20199,517,988PHENOL DERIVATIVE AND PREPARATION METHOD AND USE IN MEDICINE THEREOF7 moClosed
90/013,719Apr 7, 20168,796,001METALLOENZYME INHIBITOR COMPOUNDS12 moClosed
90/020,096Jan 18, 20168,822,438METHODS AND COMPOSITIONS FOR TREATING CANCER—Closed
90/020,086Jul 13, 20158,618,179COMPOSITION COMPRISING A PESTICIDE AND AN ALKOXYLATE OF 2-PROPYLHEPTYLAMINE18 moClosed
90/013,542Jul 3, 20158,952,045AMINO ACID COMPOSITIONS17 moClosed
90/013,539Jun 26, 20158,466,187AMINO ACID COMPOSITIONS19 moClosed
90/013,525Jun 26, 20158,178,572AMINO ACID COMPOUNDS17 moClosed
90/013,526Jun 26, 20158,183,288AMINO ACID COMPOUNDS18 moClosed
90/013,516Jun 16, 20158,569,368AMINO ACID COMPOUNDS19 moClosed
90/013,213Apr 11, 20148,674,112Polymorph of a Pharmaceutical10 moClosed
90/013,122Jan 16, 20148,114,900AMORPHOUS CARVEDILOL DIHYDROGEN PHOSPHATE7 moClosed
90/013,107Jan 8, 20146,992,218Method for Obtaining Aqueous Formulations of Oxidation-Sensitive Active Principles20 moClosed
90/012,932Jul 26, 20137,985,414POLYURETHANES FOR OSTEOIMPLANTS9 moClosed
90/012,916Jul 9, 20138,466,187AMINO ACID COMPOSITIONS42 moClosed
90/012,824Mar 30, 20135,690,988PET FOOD COMPOSITION OF IMPROVED PALATABILITY AND A METHOD OF ENHANCING THE PALATABILITY OF A FOOD COMPOSITION40 moClosed
90/012,759Dec 31, 20126,849,595Calorically Dense Nutritional Composition22 moClosed
90/012,720Nov 16, 20125,641,805Topical Ophthalmic Formulations for Treating Allergic Eye Diseases15 moClosed

Other USPTO reexam examiners

Get the full reexam analytics

Compare Dwayne C Jones against the full corpus, see the certificate-outcome split, drill into event timing, filter the case list, and export. Free to sign up.